Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
Appointment of Certain Officers
On December 8, 2022, the Board of Directors (the "Board") of Philip Morris
International Inc. (the "Company") approved the appointment of Jorge Insuasty as
the full-time President, Vectura Fertin Pharma, effective January 1, 2023. In
connection with this appointment, Mr. Insuasty will no longer also serve as
Chief Life Sciences Officer of the Company and Badrul Chowdhury, the Company's
Chief Life Sciences Officer, Smoke-Free Products, will report directly to the
Company's Chief Executive Officer, Jacek Olczak.
Mr. Insuasty will continue to report directly to Mr. Olczak, and no changes were
made to Mr. Insuasty's compensation arrangements in connection with the change
in his role.
Compensatory Arrangements of Certain Officers
As part of the Company's regional restructuring and as previously disclosed in
the Company's Current Report on Form 8-K filed on November 25, 2022, Frederic de
Wilde, currently President, European Union Region, will be appointed President,
South and Southeast Asia (SSEA), Commonwealth of Independent States (CIS),
Middle East and Africa (MEA) Region. In connection with the foregoing, on
December 8, 2022, the Board approved the following changes to Mr. de Wilde's
compensation, to be effective on his appointment:
Mr. de Wilde will be promoted to salary grade 26 and his base salary will be
increased to CHF 1,000,008 (approximately $1,080,009 at the current exchange
rate). Mr. de Wilde's annual incentive compensation award target will be at 125%
of his new base salary and his equity award target will be at 275% of his new
base salary. The Company will provide additional information regarding the
compensation of its named executive officers in the Company's proxy statement
for the 2023 Annual Shareholders Meeting.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
PHILIP MORRIS INTERNATIONAL, INC. 
